MIRA
MIRA Pharmaceuticals, Inc. Common Stock
NASDAQ: MIRA · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$1.05
+2.94% today
Updated 2026-04-30
Market cap
$42.86M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.35
Dividend yield
—
52W range
$1 – $2
Volume
0.2M
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-67993.00 | $-1.38M | $-5.60M | $-4.53M | $-5.56M | $-4.66M |
| Capital expenditures | $3.00 | $0.00 | $0.00 | $1.00 | $4.00 | $0.00 |
| Depreciation | — | — | — | $732292.00 | — | — |
| Stock-based comp | — | $0.00 | $1.30M | $2.55M | $1.92M | $6.31M |
| Free cash flow | $-67996.00 | $-1.38M | $-5.60M | $-4.53M | $-5.56M | $-4.66M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | $71120.00 | $4.18M | $3.15M | $8.78M | $3.79M | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |